Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort. Issue 2 (May 2016)

• Record Type: Journal Article
• Authors: Conway, Jessica L.; Yurkowski, Emily; Glazier, Justin; Gentles, Quinn; Walter, Allison; Bowering, Gale; Curtis, Susan; Schellenberg, Devin; Halperin, Ross; Lapointe, Vincent; Beckham, Wayne; Olivotto, Ivo A.; Olson, Robert Anton
• Is Part Of: Radiotherapy and oncology. Volume 119:Issue 2(2016:May)
• Page Start: 202
• Page End: 207
• Publication Date: 2016-05
• Subjects: Palliative radiotherapy -- Radiation therapy fractionation -- Population-based; Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/j.radonc.2016.03.025
• Languages: English
• ISSNs: 0167-8140

Abstract

Abstract: Background: Despite randomized control trials showing equivalent efficacy between single-fraction (SF) and multiple-fraction (MF) radiation therapy (RT) for bone metastases (BoM), considerable variation in fractionation exists. We compared patient-reported outcomes (PROs) following SF versus MF RT in a population-based cohort. Methods: PROs were chosen to assess patients' perception of pain, function, and symptom frustration. Total score was the sum of the 3 questions. Results: 968 patients completed pre and post-RT PROs, 35% (335) had complicated BoM. Overall, there were no differences in total score improvement (79% vs. 83%; p = 0.13), nor for complicated BoM (77% vs. 84%; p = 0.12), SFRT and MFRT respectively. On multivariate analysis no differences in improvement in total score were observed between SFRT and MFRT overall (OR = 0.71; 95% CI 0.49–1.02; p = 0.06), nor for complicated BoM (OR = 0.74; 95% CI 0.39–1.39; p = 0.35). In the complicated BoM subset, pain complete response (CR) (19% vs. 33%; p = 0.01) and functional improvement occurred more commonly in the MFRT group (69% vs. 81%; p = 0.04). Conclusion: Improvements in PROs for pain, function and symptom frustration were similar between SFRT and MFRT supporting the use of hypofractionated regimens. Using a simple, 3-question, telephone-based questionnaire to assess response to palliative RT is a feasible strategy to collect PROs.